Latin America Health Times: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Latin America Health Times.

Press releases published on September 14, 2026

18 minutes ago

Cellectis Announces Strategic Transformation To In Vivo Gene Editing Company

Indeterminate GlobeNewswire

18 minutes ago

Cellectis annonce sa transformation stratégique en société d'édition du génome in vivo

Indeterminate GlobeNewswire

41 minutes ago

Avance Clinical 在台灣榮獲 ANZCham 澳洲台灣商業傑出貢獻獎

Indeterminate GlobeNewswire

an hour ago

Unilabs Advances Digital Pathology Across Europe with Proscia, Shaping the Future of Precision Medicine

Indeterminate GlobeNewswire

an hour ago

Unilabs treibt mit Proscia die digitale Pathologie in ganz Europa voran und gestaltet die Zukunft der Präzisionsmedizin

Indeterminate GlobeNewswire

an hour ago

NANOBIOTIX Announces Complete Full Cohort Phase 1 Results for JNJ-1900 (NBTXR3) in Inoperable, Recurrent Non-Small Cell Lung Cancer

Indeterminate GlobeNewswire

an hour ago

Unilabs accélère la transformation numérique de la pathologie européenne avec Proscia, pour façonner l'avenir de la médecine de précision

Indeterminate GlobeNewswire

an hour ago

NANOBIOTIX annonce les résultats complets de la phase 1 pour JNJ-1900 (NBTXR3) dans le cancer du poumon non à petites cellules inopérable et récurrent

Indeterminate GlobeNewswire

an hour ago

Avacta Appoints Mats Blom to the Board of Directors as Chair of Audit Committee

Indeterminate GlobeNewswire

2 hours ago

Basileas Partner Asahi Kasei Therapeutics startet klinische Studie mit Antipilzmittel Cresemba® (Isavuconazol) bei Kindern in Japan

Indeterminate GlobeNewswire

2 hours ago

Basilea announces start of clinical study by partner Asahi Kasei Therapeutics in Japan with antifungal Cresemba® (isavuconazole) in pediatric patients

Indeterminate GlobeNewswire

2 hours ago

Beverly Wilshire Aesthetics Beverly Hills Medical Spa Announces Global Rebrand, Expanding Botox, Dermal Fillers, and Morpheus8 Services

Indeterminate GlobeNewswire